In the 1990s, while most of the world was still figuring out dial‑up, Karina Sotnik was in Silicon Valley helping big tech companies figure out something harder: how to go global.
Her job was international business development, not slide decks about it. She was on planes, in boardrooms, translating between cultures and markets, learning how products actually move across borders and what breaks when they do.
That early work wired her brain for one specific problem: taking innovation from “works here” to “works everywhere.” It’s the throughline that eventually led to the WorldUpstart US Market Gateway Accelerator, and why it looks so different from a typical startup program.
From corporate operator to Philly retail founder, then into accelerators
Karina eventually left Silicon Valley and landed in Philadelphia, trading corporate life for something much scrappier: her own retail business.
Running a shop is about as far from a global strategy role as you can get, and that’s the point. She had to deal with cash flow, hiring, inventory, landlords, and the daily grind that corporate strategy decks never mention.
That experience gave her something she hadn’t had before: founder empathy. Not “I’ve advised founders” empathy, but “I’ve made payroll and worried about rent” empathy.
From there, the path bent again.
Karina moved into building and running accelerators, first at the University of Pennsylvania and then at the University City Science Center in Philadelphia.
At Penn, she worked with innovation coming out of a world‑class research institution. At the Science Center, she was closer to the regional ecosystem: startups, corporates, investors, and city stakeholders all trying to pull in the same direction.
Those roles forced her to get very specific about three things.
First, selection: who actually benefits from an accelerator and who just wants the logo. Second, ecosystem building: how to connect founders to the right people, not just more people. Third, commercialization in life sciences and MedTech: how you go from lab result or prototype to something a hospital will buy and a regulator will approve.
Working with founders across those programs, she saw the same pattern: international teams with strong science and tech, but a steep learning curve on US regulation, reimbursement, and investor expectations.
Why WorldUpstart was built for the “outsider” founder
WorldUpstart is Karina’s answer to that pattern.
She took her Silicon Valley global expansion experience, combined it with what she learned building university and Science Center accelerators, and turned it into a focused program: the WorldUpstart US Market Gateway Accelerator for international MedTech and life sciences startups.
It’s not a generic “innovation bootcamp.” It’s built for founders who are already strong in science and engineering but are outsiders to the US market.
That shows up in the way the program runs.
It’s hands‑on and very founder‑centric, especially for lean or solo international founders who don’t have a big US team or a local cofounder.
Instead of just giving them content, the program surrounds them with mentors, domain experts, and a curated network inside the Philadelphia startup ecosystem and beyond.
For MedTech and life sciences, the hard part isn’t writing code or building a prototype.
The hard part is navigating FDA pathways, clinical validation, reimbursement, hospital procurement, and the way US investors think about risk and timelines in regulated markets.
WorldUpstart’s model is designed to compress that learning curve. Founders get direct exposure to how US regulatory strategy, commercialization, and fundraising actually work in practice, not just in theory.
If you look at WorldUpstart’s team bios, you see that this isn’t a one‑person show. Karina has built a bench of people who’ve lived inside pharma, med device, health systems, and venture, and who are willing to get in the weeds with founders.
That’s the difference between a curriculum and an accelerator that can actually move an international MedTech startup into the US market.
What the track record looks like in real numbers
Over time, WorldUpstart has worked with founders from more than 20 countries, many of them coming from strong science and engineering hubs but with limited US presence.
These aren’t idea‑stage projects. They’re companies with real tech that need a bridge into a complex, regulated market.
Through the US Market Gateway Accelerator, those companies have gone on to raise follow‑on funding, secure pilots, and in some cases reach FDA approvals or clearances that unlock the US as a serious commercial market.
Founders consistently point to two things when they talk about the program.
First, access to top‑tier corporate partners and health system stakeholders they would never reach cold from abroad.
Second, the support network: mentors, alumni, and local connectors who don’t disappear after demo day.
WorldUpstart also acts as a soft landing pad into Philadelphia’s innovation ecosystem.
Instead of dropping into the US with no context, founders plug into a city with major health systems, research institutions, and a growing life sciences startup scene.
That’s part of why WorldUpstart shows up on lists of serious health and MedTech programs, like this roundup of healthcare startup accelerators and incubators.
The point isn’t that every company becomes a unicorn. The point is that the program measurably improves their odds of not wasting years and runway trying to guess how the US market works.
Karina’s core bet: you don’t do this alone
If you read Karina’s own account of her journey, a theme keeps showing up: she doesn’t believe in the solo hero founder myth.
Her view is simple: global expansion is a team sport. Not just your internal team, but your extended “tribe” — mentors, peers, local champions, and ecosystem partners.
That philosophy is baked into WorldUpstart’s design. The accelerator isn’t just a series of workshops; it’s a way to quickly assemble the tribe an international MedTech founder needs to have a real shot in the US.
For international founders, this matters more than most people admit.
You’re dealing with time zones, culture gaps, regulatory uncertainty, and investors who may not understand your home market.
Trying to brute‑force that alone is a good way to burn out or stall out.
Karina’s model says: don’t.
Instead, plug into a community that already understands the terrain, especially in a city like Philadelphia where health systems, universities, and startups are used to working together.
Use programs like the WorldUpstart US Market Gateway Accelerator not as a badge, but as infrastructure — a way to borrow experience, relationships, and pattern recognition you don’t have yet.
If you’re building an international MedTech or life sciences company and the US is on your roadmap, the practical move isn’t to “go it alone and figure it out.”
The practical move is to find the tribe that’s already done this dozens of times and let them shorten your path.
That’s the bet Karina made when she built WorldUpstart, and it’s why those early days in 1990s Silicon Valley still echo through the work she’s doing with founders now.
For more on the program and whether it fits where you are, start with the source: WorldUpstart’s site has details on the US Market Gateway Accelerator and how they work with international teams.
